PemigatinibA Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Sponsor:

Sameek Roychowdhury

Code:

NCT06906562

Conditions

Advanced Pancreatic Carcinoma

Metastatic Pancreatic Carcinoma

Stage II Pancreatic Cancer AJCC v8

Stage III Pancreatic Cancer AJCC v8

Stage IV Pancreatic Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pemigatinib

Computed Tomography (CT)

Magnetic Resonance Imaging

Optical Coherence Tomography

Bone Scan

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Sameek Roychowdhury on 2026-02-17.